Expression of SLC7A5 has been detected in a variety of tumor cells, including thyroid cancer, teratocarcinoma, bladder cancer, lung cancer, melanoma, hemangiopericytoma, and uterine cervical cancer [29–31]. Here, SLC7A5 is linked to urinary bladder cancer.